As in a batch of kombucha or a barrel of sherry, microbes can assemble into a mat-like layer at the boundary between air and ...

Analysis from continued follow-up of Phase 1/2 clinical trial data in Hunter syndrome (MPS II) reinforces potential for tividenofusp alfa ...

Real-world and clinical trial data underscore long-term safety and effectiveness in pediatric and adult NPC patients ...

As we age, our cells don’t just wear down—they reorganize. Researchers found that cells actively remodel a key structure called the endoplasmic reticulum, reducing protein-producing regions while ...

Parkinson's disease (PD) is the second most common neurodegenerative disease after Alzheimer's disease, affecting more than 10 million people ...

Although scientists have known some of the factors that raise a person’s risk of Parkinson's disease, the question remains of why some people with genetic risk factors develop the disease while others ...

Data from up to 42 months of treatment reinforce lucerastat’s potential as a first-in-class oral substrate reduction therapy addressing key unmet needs across the Fabry populationThe company is ...

Functioning brain cells need a functioning system for picking up the trash and sorting the recycling. But when the cellular ...

Together with colleagues from Stanford University, USA, researchers at the Leibniz Institute on Aging - Fritz Lipmann Institute (FLI) have, for the first time, created a comprehensive cell ...

Cell-type resolved protein atlas of brain lysosomes identifies SLC45A1-associated disease as a lysosomal disorder. Ali Ghoochani, Julia C. Heiby, Eshaan S. Rawat, Uche N. Medoh, Domenico Di Fraia, ...

Many species of fungus across the world produce psilocybin, a chemical with psychedelic effects in humans, but its ...

Some four miles off the Southern California coast, a company is betting it can solve one of desalination’s biggest problems by moving the technology deep ...